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Abstract
This study aimed to test the association between dietary content of total and individual classes of polyphenols and incident cases of type 2 diabetes
in Polish adults participating to the Health, Alcohol and Psychosocial factors In Eastern Europe study. At baseline, diet by 148-item FFQ and health
information were collected from 5806 participants free of diabetes. Self-reported incident type 2 diabetes was ascertained at 2–4-year follow-up
visit. OR and 95% CI of type 2 diabetes comparing the various categories of polyphenol intake to the lowest one (reference category) and as
1 SD increase modelled as continuous variable were calculated by performing age-, energy-, and multivariate-adjusted logistic regression models.
During the follow-up, 456 incident cases of type 2 diabetes occurred. When comparing extreme quartiles, intake of total polyphenol was inversely
associated with the risk of type 2 diabetes (OR 0·43; 95% CI 0·30, 0·61); 1 SD increase was associated with a reduced risk of diabetes (OR 0·68; 95%
CI 0·59, 0·79). Among the main classes of polyphenols, ﬂavonoids, phenolic acids, and stilbenes were independent contributors to this association.
Both subclasses of phenolic acids were associated with decreased risk of type 2 diabetes, whereas among subclasses of ﬂavonoids, high intake of
ﬂavanols, ﬂavanones, ﬂavones and anthocyanins was signiﬁcantly associated with decreased risk of type 2 diabetes. Total dietary polyphenols and
some classes of dietary polyphenols were associated with lower risk of type 2 diabetes.
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Plant-derived dietary pattern have been suggested to exert
protection against metabolic disorders, such as type 2 diabetes(1).
Among the most attractive hypotheses potentially explaining
the beneﬁts associated with high consumption of fruits and
vegetables, polyphenols content is one of the best candidates as
determinant of health. In fact, besides the known macro- and
micronutrients contained in fruit and vegetables, polyphenols are
highly representative in beverages such as coffee, tea and some
alcoholic beverages that have demonstrated to have a positive
impact on human health(2). Polyphenolic compounds are
molecules highly contained in the aforementioned food and
plant-derived beverages divided into four main classes on the
basis of their chemical structure, including ﬂavonoids, phenolic
acids, stilbenes, and lignans, and ‘other’ polyphenols including
various type of compounds(3). Overall, polyphenols comprise
thousands of different molecules have been classiﬁed and
described. Even though, the main challenges of studying these
compounds rely on the identiﬁcation of their potential effects in
humans. In vitro studies demonstrate consistently antioxidant and
anti-inﬂammatory effects at cellular and tissue level, but questions
remain regarding their effective relevance for human health, as
exposure in normal diet occur at lower concentrations than in
laboratory setting(3,4).
Although causality is best supported by randomised trials,
observational epidemiological studies also contribute to causal
inference and are of great interest to evaluate the ‘real world’
consumption of polyphenols and their potential association
with health outcomes. Regarding metabolic disorders, type 2
diabetes has been one of the most studied outcome evaluated
in epidemiological studies. A relatively recent meta-analysis
showed that increased intake of ﬂavonoids, especially
ﬂavonols, may decrease the risk of type 2 diabetes(5). However,
available data on type 2 diabetes prevalence and incidence is
focused only on ﬂavonoids. Only recently research has
expanded to other polyphenol groups, such as phenolic acids
and individual subgroups but data are overall scarce. Moreover,
as polyphenol consumption varies with a great extent with
the dietary habits of a population, it is of interest to collect
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information from various countries in order to provide stronger
evidence of their potential effects. In this study, we aimed to test
the association between dietary content of total and individual
classes of polyphenols and self-reported incident cases of type
2 diabetes in Polish adults participating to the Health, Alcohol
and Psychosocial factors in Eastern Europe (HAPIEE) study.
Methods
Study population
The HAPIEE study is a multicenter prospective cohort study
investigating the role of biological, dietary, lifestyle and
environmental factors in cardiovascular and other chronic
diseases(6). Information on methods used are reported in detail
elsewhere(6). The present study was conducted on a subcohort
of the Polish arm of the HAPIEE cohort (a random sample
of 10 728 adults aged 45–69 years recruited in 2002–2005
(response ratio of 59%) in the urban area of Krakow, Poland)
which was free of diabetes or impaired fasting glucose
(fasting plasma glucose from 6·1 to 6·9mmol/l) at baseline
(n 9420). Study participants completed a structured questionnaire
and underwent to a clinical examination during the baseline data
collection (wave I) and at follow-up visit (wave II). Participants
were followed for a median follow-up period of 4 years
(range 3·2–5·4 years). For the purpose of this study, only
individuals free of diabetes at baseline who attended the last
follow-up visit in 2006–2008 were included in the analysis
(n 5806, 54% of original cohort). Sample included in the analysis
did not substantially differ in background characteristics or
variables of interest concerning dietary habits. All participants
provided written informed consent before joining the study.
Dietary assessment
Dietary data were collected by using a FFQ previously
validated(7,8). The FFQ consisted of 148 food and drink items
accompanied by a country-speciﬁc instruction manual that
included photographs to facilitate the estimation of portion
sizes. Participants were asked how often, on average, they had
consumed that amount of the item during the last 3 months,
with nine responses ranging from ‘never or less than once per
month’ to ‘six or more times per day’. Participants were also
asked to include additional foods and frequency of consum-
ption by manual entry.
Estimation of polyphenol intake
Data on the polyphenol content in foods were obtained from
the Phenol-Explorer database (www.phenol-explorer.eu)(9).
The process of estimation of polyphenol intake has
been described in details elsewhere(10). In brief, food items of
the FFQ containing more food components were separated
according to their ingredients and foods that contained no
polyphenols were excluded from the analysis. The average
food consumption was calculated (in g or ml) by following
the standard portion sizes used in the study and then
converted in 24-h intake. An advanced search was carried out in
the Phenol-Explorer database to retrieve mean content values for
all polyphenols contained in the foods obtained and individual
polyphenol intake from each food was calculated by multiplying
the content of each polyphenol by the daily consumption of each
food. Total polyphenol intake was calculated as the sum of all
individual polyphenol intake from all food sources encountered
according to this process. In this study we investigated exposure
to total polyphenols and their main classes phenolic acids, ﬂa-
vonoids, stilbenes and lignans; the main subclasses of phenolic
acids, including hydroxybenzoic acids and hydroxycinnamic
acids; the main subclasses of ﬂavonoids, including ﬂavanols,
ﬂavonols, ﬂavanones, ﬂavones, anthocyanins, and isoﬂavones;
and ‘other’ polyphenols, including alkylmethoxyphenols, alkyl-
phenols, curcuminoids, furanocoumarins, hydroxybenzaldehydes,
hydroxybenzoketones, hydroxycinnamaldehydes, hydroxy-
coumarins, hydroxyphenylpropenes, methoxyphenols, naphto-
quinones, phenolic terpenes and tyrosols.
Demographic, lifestyle and clinical measurements
Socio-demographic and lifestyle characteristics included age,
sex, educational and occupational level, smoking and alcohol
drinking habits. Physical activity included energy expenditure
in leisure time by reporting type and duration of activity
according the predetermined questionnaire items. The overall
amount of energy expenditure was estimated in kJ (kcal/d)
and categorised in low, moderately and high activity level.
Individuals were categorised according their smoking status as
non-smoker and current smoker. Alcohol consumption was
categorised as (i) non-drinkers (ii) drinkers; alcohol intake was
considered as a continuous variable (g/d).
Physical examination included measurement of height,
weight, waist circumference and blood pressure using standard
procedures(6). BMI was calculated according to the formula
weight (kg)/height (m2).
Outcome assessment
Participants were considered to have type 2 diabetes at baseline
if they had elevated glucose concentrations (plasma glucose
concentrations of ≥7mmol/l) or treatment with hypoglycaemia
medications (insulin or oral hypoglycaemia agent) within the
last 2 weeks. Among individuals free of diabetes at baseline,
cases of new type 2 diabetes were deﬁned as those participants
self-reporting of being professionally diagnosed with type 2 or
taking hypoglycaemia medications within the last two weeks at
follow-up.
Statistical analysis
We categorised individual ﬂavonoids by dividing intake into quar-
tiles and providing mean intakes for each category of exposure
(expressed as glycosides and esters). Characteristics of the study
cohort were described by quartiles of total polyphenol consump-
tion. Sex-speciﬁc analyses were conducted. Descriptive presenta-
tion relied on cross tabulations. Continuous variables are presented
as means and standard deviations, categorical variables as
counts and percentages. Variables were examined for normality
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(Kolmogorov test). The χ2 test was used for comparisons of cate-
gorical variables, the Kruskal–Wallis test was used for continuous
variables because these variables did not ﬁt a normal distribution.
The association between baseline consumption of polyphenols
and incident type 2 diabetes was assessed by logistic regression
analyses. Age- and energy-adjusted, and multivariable-adjusted
models were performed: OR and 95% CI of having type 2
diabetes were calculated for polyphenols considered as both
categorical (quartiles, with the lower category of polyphenol con-
sumption as reference) and continuous exposure (1 SD increase
intake). Tests for linear trends were also performed by assigning
the medians of each quartile as scores. Variables included in the
multivariable model were age, total energy intake, BMI, physical
activity, educational status, smoking status, alcohol consumption,
alcohol intake, ﬁbre and menopausal status (women only). As
Spearman correlation test showed signiﬁcant correlation between
main classes of polyphenols and subclasses of ﬂavonoids (data not
shown), we did not include in the model all main classes of
polyphenols/ﬂavonoids. Graphical representation using restricted
cubic splines analysis for total polyphenols was applied. When
examining the association with total polyphenols, a sensitivity
analysis was performed by including one at the time the major food
sources of polyphenols based on our previous publication(10), to
test whether the level of association was driven by one individual
food component. Statistical signiﬁcance was accepted at P<0·05.
All statistical analyses were performed with SPSS for Windows 21.0
(SPSS Inc.).
Results
Baseline characteristics of individuals free of diabetes by
quartiles of total polyphenol intake are presented in Table 1.
Age and BMI were signiﬁcantly lower with increasing poly-
phenol intake. In contrast, energy intake, ﬁbre, alcohol drinkers
and alcohol intake increased through quartiles of polyphenol
consumption. Finally, among individuals with higher intake of
polyphenols there were more smokers and physically active
(Table 1). Major food contributors for total polyphenol intake
were coffee and tea, representing the major contributors
of phenolic acid and ﬂavonoid classes, respectively (online
Supplementary Table S1). Among fruits and vegetables, other
important contributors of ﬂavonoids were black currant, apples,
strawberries, beans and oranges. Regarding lignans and
stilbenes, major food sources were seeds and red wine,
respectively; ‘other’ polyphenols were mainly contained in
beer, cereals, and coffee (online Supplementary Table S1).
During follow-up, 456 incident cases of type 2 diabetes
occurred. In fully adjusted analyses, the highest intake of total
Table 1. Background characteristics of participants in the Health, Alcohol and Psychosocial factors in Eastern Europe cohort free of diabetes at baseline by
quartiles (Q) of total polyphenol intake (energy adjusted)
(Numbers and percentages; mean values and standard deviations)
Polyphenol quartiles (men)
Q1 Q2 Q3 Q4
n % n % n % n % Pfor trend
No. of subjects 1347 1454 1481 1524
Age (years) <0·001
Mean 57·7 57·9 57·3 56·6
SD 6·9 6·9 6·8 6·8
Men 645 47·9 656 45·1 698 47·1 732 48·0 0·632
BMI (kg/m2) <0·001
Mean 28·1 27·8 27·8 27·3
SD 4·3 4·3 4·3 4·1
Current smoker 409 30·5 451 31·0 454 30·8 528 34·7 0·022
Educational level 0·056
Low 135 10·1 162 11·2 143 9·7 134 9·9
Medium 818 61·0 859 59·2 895 60·4 878 59·5
High 389 29·0 430 29·6 443 33·6 512 30·6
Physical activity level 0·010
Low 385 30·1 401 29·3 377 26·8 398 27·4
Medium 483 37·8 517 37·7 534 37·9 530 36·6
High 409 32·0 452 33·0 498 35·3 522 36·0
Alcohol drinkers 582 43·2 743 51·1 820 55·4 858 56·3 <0·001
Alcohol intake (g/d) <0·001
Mean 2·16 2·34 2·99 3·31
SD 5·64 5·73 7·01 9·23
Total energy intake (kJ/d) <0·001
Mean 7524 8490·50 9345·80 10 335·65
SD 2204·29 2178·35 2449·43 2833·32
Total energy intake (kcal/d) <0·001
Mean 1798·28 2029·28 2233·70 2470·28
SD 526·84 520·64 585·43 677·18
Fibre intake (mg/d) <0·001
Mean 15·85 18·02 19·70 22·17
SD 5·53 5·94 7·18 8·94
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polyphenols was associated with lower risk of type 2 diabetes
in the whole population (Table 2) and individually in both men
and women (OR 0·31; 95% CI 0·18, 0·52 and OR 0·53; 95% CI
0·33, 0·85, respectively; online Supplementary Table S2)
compared with the lowest. The relation was linear (Fig. 1) and
1 SD increased intake of polyphenols was associated with a 32%
reduced risk of diabetes (OR 0·68; 95% CI 0·59, 0·79). The
sensitivity analysis by adjusting for major food sources of
polyphenols showed no differences with previous results
(data not shown). Among the main classes of polyphenols,
ﬂavonoids, phenolic acids and stilbenes were contributors
to this association. When considering individual subclass
contributors among phenolic acids, both hydroxybenzoic acids
and hydroxycynnamic acids showed an inverse relation with
type 2 diabetes in a linear dose–response manner (Table 3).
However, separate analyses by sex showed that higher intake
of hydroxybenzoic acids was associated with decreased risk of
type 2 diabetes mainly in men (online Supplementary Table S3).
Among individual subclasses of ﬂavonoids, ﬂavanols,
ﬂavanones, ﬂavones and anthocyanins were independently
associated with decreased risk of type 2 diabetes in a linear
dose–response manner (Table 4). Analyses separated by sexes
showed similar results on ﬂavones, whereas most of
other results were more evident in men (online Supplementary
Table S4). The association between other polyphenols and
risk of type 2 diabetes resulted in null results for the whole
cohort (Table 5) and individually for men and women (online
Supplementary Table S5).
Discussion
In this study we observed that individuals with higher total
dietary polyphenol intake were less likely to develop type 2
diabetes compared with those in the lowest quartile of intake.
Among individual classes studied, hydroxycinnamic acids and
hydroxybenzoic acids among phenolic acids, and ﬂavanols,
ﬂavanones, ﬂavones and anthocyanins among ﬂavonoids
resulted to be associated with lower risk of type 2 diabetes.
Flavonoids are mainly contained in fruit, vegetable and tea,
which have been associated with beneﬁts toward metabolic
disorders(11,12). These results are consistent with previous
ﬁndings of the cross-sectional analysis of baseline data from the
same cohort in which we found that the same classes of ﬂavo-
noids were associated with lower odds of having impaired
Table 2. Association between cumulative polyphenol intake (total and main groups) and incidence of type 2 diabetes
(Mean values and standard deviations; odds ratios and 95% confidence intervals)
Polyphenol quartiles
Q1 Q2 Q3 Q4 1 SD increase
OR 95% CI OR 95% CI OR 95% CI OR 95% CI Pfor trend OR 95% CI
Total polyphenols (mg/d)
Mean 1026·7 1469·6 1872·6 2632·1
SD 212·0 102·2 136·7 608·0
No. of cases 167 121 91 77
Model 1* 1 0·69 0·54, 0·89 0·54 0·41, 0·71 0·47 0·35, 0·64 <0·001 0·72 0·63, 0·81
Model 2† 1 0·77 0·58, 1·01 0·48 0·35, 0·66 0·43 0·30, 0·61 <0·001 0·68 0·59, 0·79
Total flavonoids (mg/d)
Mean 501·8 756·4 958·2 1452·3
SD 125·1 55·6 69·8 509·4
No. of cases 165 122 92 77
Model 1* 1 0·76 0·59, 0·98 0·57 0·43, 0·75 0·53 0·39, 0·72 <0·001 0·77 0·67, 0·89
Model 2† 1 0·75 0·56, 0·99 0·50 0·36, 0·68 0·44 0·30, 0·63 <0·001 0·72 0·61, 0·84
Phenolic acids (mg/d)
Mean 288·5 615·8 829·3 1482·0
SD 85·5 60·6 162·9 298·5
No. of cases 126 137 114 79
Model 1* 1 1·03 0·80,1·33 0·95 0·73,1·25 0·64 0·47,0·86 <0·001 0·80 0·72, 0·90
Model 2† 1 1·13 0·85, 1·50 0·92 0·68, 1·25 0·60 0·42, 0·84 0·001 0·80 0·71, 0·91
Stilbenes (mg/d)
Mean 0·004 0·016 0·046 0·598
SD 0·003 0·005 0·013 1·336
No. of cases 169 102 107 78
Model 1* 1 0·60 0·46, 0·78 0·62 0·48, 0·81 0·40 0·30, 0·54 <0·001 0·90 0·75, 1·07
Model 2† 1 0·59 0·44, 0·79 0·54 0·40, 0·73 0·34 0·24, 0·48 <0·001 0·92 0·77, 1·11
Lignans (mg/d)
Mean 0·16 0·24 0·31 1·36
SD 0·04 0·01 0·02 19·55
No. of cases 121 103 114 118
Model 1* 1 0·98 0·74, 1·30 1·11 0·84, 1·45 1·25 0·95, 1·65 0·672 0·98 0·87, 1·11
Model 2† 1 0·98 0·71, 1·34 1·15 0·85, 1·56 1·18 0·86, 1·61 0·534 1·00 0·88, 1·13
Q, quartile.
* Adjusted for age (continuous) and total energy intake (continuous).
† Model 1 +adjusted for BMI (continuous), physical activity (low/medium/high), educational status (low/medium/high), smoking status (yes/no), alcohol consumption (yes/no),
alcohol intake (continuous), menopausal status (women only, yes/no) and dietary fibre (continuous).
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glucose metabolism(13). Such ﬁndings may explain the results of
previous observations showing better outcomes related with
plant-based dietary patterns in the HAPIEE cohort(14–16). Recent
prospective studies reported certain beneﬁts for higher intakes
of anthocyanins(17), ﬂavanols and ﬂavonols(18,19), despite
contrasting results have been also published(20,21). Findings
from meta-analyses regarding the potential beneﬁts of ﬂavo-
noids on type 2 diabetes(5) and glycaemic control(22) also pro-
vided evidence of association between some ﬂavonoid classes
and decreased risk of type 2 diabetes. From a mechanistic point
of view, ﬂavonoids may reduce biological pathways related to
the development of type 2 diabetes by improving endothelial
function, which has been correlated with insulin resistance(23).
Moreover, experimental studies in vitro and in vivo demon-
strated that ﬂavonoids interact with molecular targets and affect
signalling pathways resulting in improvement of glycaemia and
suppression of gluconeogenesis(24–26). Despite we found some
null results regarding the ﬂavonol class, which has been
previously related with health beneﬁts associated with tea
consumption(27), some limitations of our study, including
reverse causation and genetics related to high tea consumption
may explain our unexpected ﬁndings.
In this study, hydroxybenzoic and hydroxycinnamic acids, the
main subclasses of phenolic acids, were both inversely associated
with the risk of type 2 diabetes. Among the most studied
hydroxycinnmic acids, chlorogenic acids (CGA) which are
contained in coffee, have been reported to exert beneﬁcial effects
towards cardiovascular risk factors and metabolic disorders(28).
We previously showed in the HAPIEE cohort the association
between coffee and metabolic disorders, including type 2
diabetes(29). Meta-analyses of observational studies conducted on
coffee reported signiﬁcant decreased risk of type 2 diabetes and
general metabolic disorders(12,30). Together with their antioxidant
properties, CGA have been found to exert direct effects in
regulating glucose metabolism(31). CGA have been hypothesised
to exert effects on glucose metabolism through their speciﬁc
competitive inhibition of the glucose-6-phosphate translocase,
which in turn inhibit gluconeogenesis, and activation of
AMP-activated protein kinase, a sensor and regulator of cellular
energy balance that may lead to suppression of hepatic glucose
production and fatty acid synthesis(32).
Studies on stilbenes have been mostly focused on the effects of
resveratrol on cardio-metabolic health(33). A recent meta-analysis
on resveratrol treatment as an adjunct to pharmacological
management in type 2 diabetes mellitus reported a signiﬁcant
reduction of fasting glucose, insulin, glycated Hb (HbA1c) and
insulin resistance levels in participants with type 2 diabetes(34) but
did not affect glycaemic measures in non-diabetic individuals(35).
We reported that high total stilbenes intake was related with
decreased incidence of type 2 diabetes, thus conﬁrming earlier
ﬁndings derived from clinical setting. The main effects of stilbenes
in human health are relative to their role in cellular defense against
oxidative stress through the nuclear factor-erythroid-2-related
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Fig. 1. Association between total polyphenol intake and incidence of type 2
diabetes.
Table 3. Association between phenolic acid subclasses and incidence of type 2 diabetes
(Mean values and standard deviations; odds ratios and 95% confidence intervals)
Polyphenol quartiles
Q1 Q2 Q3 Q4 1 SD increase
OR 95% CI OR 95% CI OR 95% CI OR 95% CI Pfor trend OR 95% CI
Hydroxybenzoic acids (mg/d)
Mean 43·4 85·7 91·9 157·1
SD 23·5 0·9 3·7 31·4
No. of cases 124 118 128 76
Model 1* 1 0·93 0·71, 1·21 1·19 0·91, 1·56 0·75 0·56, 1·00 0·115 0·92 0·83, 1·02
Model 2† 1 1·05 0·78, 1·42 1·18 0·87, 1·60 0·71 0·51, 0·99 0·043 0·89 0·79, 0·99
Hydroxycinnamic acids (mg/d)
Mean 188·19 530·67 724·48 1386·85
SD 73·6 66·5 168·8 292·2
No. of cases 127 128 121 80
Model 1* 1 0·95 0·73, 1·23 1·01 0·77, 1·32 0·64 0·47, 0·85 <0·001 0·81 0·73, 0·91
Model 2† 1 1·08 0·81, 1·44 0·99 0·73, 1·34 0·61 0·43, 0·86 0·001 0·80 0·71, 0·91
Q, quartile.
* Adjusted for age (continuous) and total energy intake (continuous).
† Model 1 +adjusted for BMI (continuous), physical activity (low/medium/high), educational status (low/medium/high), smoking status (yes/no), alcohol consumption (yes/no),
alcohol intake (continuous), menopausal status (women only, yes/no) and dietary fibre (continuous).
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factor-2 (Nrf2) and the potential roles of SQSTM1/p62 protein in
Nrf2/Keap1 signalling and autophagy(36). Moreover, modulation of
expression of visfatin, sirtuin-1 and GLUT (2 and 4) may improve
glucose metabolism by suppressing oxidative stress and increasing
potential to internalise glucose by extrahepatic tissues(37). Besides
the antioxidant effects, stilbenes have also been suggested to
regulate circulating leptin levels and improve insulin signalling,
both implicated in type 2 diabetes risk(38). However, the
mechanisms of action for the hypothesised effects are by far
complex and the knowledge on them is still evolving.
In the present study, no signiﬁcant results were found for
phyto-oestrogens, such as isoﬂavones and lignans. In our previous
cross-sectional analysis, we found some positive association
between impaired glucose metabolism and intake of isoﬂavones,
which have a weak oestrogenic action. These ﬁndings are
substantially in contrast with other recent studies showing that
urinary excretion of isoﬂavones and lignans or markers of con-
sumption were associated with lower risk of type 2 diabetes(39,40).
However, other epidemiological studies reported contrasting
results(41) and analyses of large European and US cohorts showed
no association of soya food intake, isoﬂavones and lignans and
risk of type 2 diabetes(42,43). Consumption of soya foods in our
cohort was very low and main food sources of phyto-oestrogens
in non-Asian population are generally legumes, whole wheat
Table 4. Association between flavonoid subclasses and incidence of type 2 diabetes
(Mean values and standard deviations; odds ratios and 95% confidence intervals)
Polyphenol quartiles
Q1 Q2 Q3 Q4 1 SD increase
OR 95% CI OR 95% CI OR 95% CI OR 95% CI Pfor trend OR 95% CI
Flavanols (mg/d)
Mean 323·65 519·72 681·84 1099·91
SD 109·97 57·01 43·89 434·73
No. of cases 151 139 86 80
Model 1* 1 0·96 0·75, 1·23 0·60 0·45, 0·80 0·59 0·43, 0·79 <0·001 0·77 0·67, 0·88
Model 2† 1 0·88 0·67, 1·17 0·59 0·43, 0·81 0·54 0·39, 0·76 0·001 0·77 0·66, 0·90
Flavonols (mg/d)
Mean 60·16 89·63 113·64 163·31
SD 14·77 6·35 7·71 46·28
No. of cases 124 114 110 108
Model 1* 1 1·00 0·77, 1·31 1·01 0·77, 1·33 1·12 0·84, 1·49 0·275 1·05 0·95, 1·16
Model 2† 1 1·00 0·73, 1·35 0·98 0·72, 1·34 0·89 0·63, 1·26 0·368 0·94 0·82, 1·07
Flavanones (mg/d)
Mean 24·68 59·64 105·55 218·88
SD 11·44 11·05 15·86 89·61
No. of cases 134 126 98 98
Model 1* 1 0·92 0·71, 1·19 0·79 0·60, 1·05 0·85 0·64, 1·13 0·178 0·92 0·82, 1·03
Model 2† 1 0·88 0·66, 1·18 0·73 0·53, 1·00 0·75 0·54, 1·03 0·047 0·88 0·77, 0·99
Flavones (mg/d)
Mean 1·96 4·28 7·93 16·53
SD 0·70 0·77 1·56 7·71
No. of cases 144 123 104 85
Model 1* 1 0·80 0·62, 1·04 0·74 0·56, 0·97 0·68 0·50, 0·92 0·188 0·92 0·81, 1·04
Model 2† 1 0·71 0·53, 0·95 0·65 0·47, 0·89 0·47 0·33, 0·68 0·021 0·84 0·72, 0·97
Anthocyanins (mg/d)
Mean 4·40 8·75 14·52 91·92
SD 2·02 1·24 2·46 185·59
No. of cases 114 141 113 88
Model 1* 1 1·32 1·01, 1·71 1·08 0·82, 1·42 0·87 0·65, 1·18 0·257 0·89 0·74, 1·08
Model 2† 1 1·18 0·88, 1·59 0·86 0·62, 1·19 0·68 0·48, 0·98 0·070 0·82 0·66, 1·01
Isoflavones (mg/d)
Mean 0·001 0·140 0·196 4·912
SD 0·001 0·001 0·001 13·659
No. of cases 74 145 131 106
Model 1* 1 0·91 0·68, 1·22 1·04 0·77, 1·41 0·90 0·65, 1·23 0·211 0·85 0·67, 1·09
Model 2† 1 0·91 0·65, 1·28 1·00 0·71, 1·40 0·93 0·65, 1·34 0·065 0·75 0·55, 1·01
Dihydrochalcones (mg/d)
Mean 1·94 6·93 9·77 25·02
SD 1·22 1·69 1·09 7·74
No. of cases 94 130 88 144
Model 1* 1 1·33 1·00, 1·76 1·05 0·77, 1·43 1·61 1·21, 2·12 0·004 1·15 1·04, 1·26
Model 2† 1 1·07 0·78, 1·46 0·84 0·59, 1·19 1·12 0·80, 1·57 0·926 0·99 0·88, 1·12
Q, quartile.
* Adjusted for age (continuous) and total energy intake (continuous).
† Model 1 +adjusted for BMI (continuous), physical activity (low/medium/high), educational status (low/medium/high), smoking status (yes/no), alcohol consumption (yes/no),
alcohol intake (continuous), menopausal status (women only, yes/no) and dietary fibre (continuous).
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products and seeds(44). Clinical trials on ﬂaxseeds and lignans and
glycaemic control showed similar contrasting results(45,46). A meta-
analysis of twenty-four intervention studies on soy and isoﬂavone
intake and glycaemic control showed no signiﬁcant effect on
fasting glucose and insulin of eight trials with isoﬂavone extract and
six studies with isolated soya protein, but reduction in fasting
glucose concentrations in nine studies that used whole soya
foods or soya diets (suggesting that components other than
phyto-oestrogens may be responsible for the potential beneﬁts)(47).
Among other issues related to the contrasting results on phytoes-
trogens has been pointed out the large inter-individual variation in
plasma concentrations of isoﬂavones, which may limit the use of
intake data for risk assessment(48). Phyto-oestrogens have been
hypothesised to ameliorate glucose metabolism and prevent type 2
diabetes by decreasing the activity of key enzymes related to
blood glucose and HbA1c levels (including hepatic glucose-
6-phosphatase and phosphoenolpyruvate carboxykinase, fatty
acid synthase, β-oxidation and carnitine palmitoyltransferase) and
activating the PPAR gene expression pathway(49). However, given
the aforementioned issues, further studies are needed to provide
stronger evidence of the biological rationale.
Other limitations should be taken into account when
considering results from this study. First, the observational design
of the study can only partially provide evidence of causation.
Second, due to relatively low response rate in the follow-up
examination, number of participants included to the analysis was
substantially lower than screened at baseline. This inﬂuenced the
representativeness of the sample negatively, but there is evidence
that low participation rate affect less the relations studied(50,51).
Nevertheless, it could contribute to an underestimation of the
associations found because of the higher no-participation in
diabetics. Third, as information on diet was collected at baseline
only, we were unable to test whether dietary habits had changed
during follow-up. However, during 4 years it is unlikely that there
was a major change in dietary habits of the population. We also
acknowledge that our assumption on the induction period
between nutritional exposure to polyphenols and T2D might
have been too short. In any case, the FFQ usually captures the
habitual diet and may represent a proxy for long-term dietary
exposures. The potentially unrealistic assumed induction period
remains a limitation of our study, and it more probably would
have produced and underestimation of the association. Fourth,
although sensitivity of diabetes self-reports is high (about
70%)(52), there is a small proportion of individuals that are
unaware of their disease. If we consider that diabetics could have
dropped the study to a larger extent than non-diabetics, this
causes that the ascertained number of cases would be under-
estimated, thus reducing the statistical power of the analyses.
However, given the prospective design of the study, it is unlikely
that this under-recording of cases would be differential according
to the exposure, thus affecting the precision, but not the validity
of the results. However, such issues are common to all previous
studies using the same methodology and as polyphenol
exposure was ascertained before diagnosis of disease,
misclassiﬁcation would tend to bias estimates toward the null and
underestimate true associations. Fifth, some polyphenol-rich
foods, such as herbs and spices, were not included in FFQ,
which might lead to underestimation of the exposure. Never-
theless we don’t expect that contribution of polyphenols from
spices and herbs in the total polyphenols intake is high enough to
materially affect the results. Fifth, use of table content databases
would have inevitably led to some misclassiﬁcation of polyphenol
intake. Sixth, consumption of some polyphenol classes (i.e.
stilbenes, lignans and isoﬂavones) in ‘normal’ diets can be
negligible, and consequently difﬁcult to be accurately estimated.
Despite we found signiﬁcant results for such polyphenol groups,
it should be considered that amount consumed was very low.
Seventh, despite we adjusted the analyses for a number of
potential confounders, other untested variables (i.e. family history
of diabetes) may contribute to residual confounding.
In conclusion, higher intake of a variety of polyphenols may
decrease the risk of type 2 diabetes. Besides the fact that results
from this study may not be generalisable to other populations,
they provide further evidence that potential association
between polyphenols intake and cardiovascular risk factors
may exist. Our study added to the current knowledge further
information regarding other polyphenol classes potentially
explaining the aforementioned contrasting results. Limitation of
previous studies investigating individual classes of polyphenols
may have led to underestimation of their effects by not taking
into account possible interactions. Further studies with experi-
mental design are needed to establish the effects that can
Table 5. Association between other polyphenols and incidence of type 2 diabetes
(Mean values and standard deviations; odds ratios and 95% confidence intervals)
Polyphenol quartiles
Q1 Q2 Q3 Q4 1 SD increase
OR 95% CI OR 95% CI OR 95% CI OR 95% CI Pfor trend OR 95% CI
Others (mg/d)
Mean 6·17 16·8 32·92 76·66
SD 3·02 3·10 5·65 37·81
No. of cases 107 103 127 119
Model 1* 1 0·92 0·69, 1·22 1·17 0·89, 1·53 1·22 0·93, 1·62 0·217 1·05 0·96, 1·15
Model 2† 1 0·94 0·68, 1·29 1·11 0·82, 1·50 1·11 0·81, 1·53 0·821 1·01 0·91, 1·12
Q, quartile.
* Adjusted for age (continuous) and total energy intake (continuous).
† Model 1 +adjusted for BMI (continuous), physical activity (low/medium/high), educational status (low/medium/high), smoking status (yes/no), alcohol consumption (yes/no),
alcohol intake (continuous), menopausal status (women only, yes/no), dietary fibre (continuous) and all main classes of flavonoids included in the table (quartiles).
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speciﬁcally attributed to each polyphenol class in order to
identify speciﬁc polyphenol-rich foods that may contribute to
the prevention of cardiovascular risk factors.
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